Dr. Megan Coylewright, MD,MPH,FACC
Claim this profileErlanger Medical Center
Affiliated Hospitals
Erlanger Medical Center
Erlanger Health System
Clinical Trials Megan Coylewright, MD,MPH,FACC is currently running
Edwards PASCAL System
for Tricuspid Regurgitation
This trial tests a new device that fixes a leaky heart valve without surgery in patients who are too risky for traditional surgery. The device helps the valve close properly to stop blood from leaking backward. The first device specifically designed for this purpose is the paravalvular leak device (PLD - Occlutech).
Recruiting
1 award
N/A
6 criteria
Left Atrial Appendage Occlusion vs. NOAC
for Atrial Fibrillation
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.
Recruiting
1 award
N/A
8 criteria
More about Megan Coylewright, MD,MPH,FACC
Clinical Trial Related
8 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Megan Coylewright, MD,MPH,FACC has experience with
- Atrial Flow Regulator
- Sham Comparator
- Amplatzer Amulet LAA Occluder
- Non-Vitamin K Oral Antagonists
- Evolut FX TAVR System
- Medtronic Evolut PRO+ TAVR System
Breakdown of trials Megan Coylewright, MD,MPH,FACC has run
Stroke
Atrial Fibrillation
Bleeding
Hemorrhage
Heart Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Megan Coylewright, MD,MPH,FACC specialize in?
Megan Coylewright, MD,MPH,FACC focuses on Stroke and Atrial Fibrillation. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Megan Coylewright, MD,MPH,FACC currently recruiting for clinical trials?
Yes, Megan Coylewright, MD,MPH,FACC is currently recruiting for 2 clinical trials in Chattanooga Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Megan Coylewright, MD,MPH,FACC has studied deeply?
Yes, Megan Coylewright, MD,MPH,FACC has studied treatments such as Atrial Flow Regulator, Sham Comparator, Amplatzer Amulet LAA Occluder.
What is the best way to schedule an appointment with Megan Coylewright, MD,MPH,FACC?
Apply for one of the trials that Megan Coylewright, MD,MPH,FACC is conducting.
What is the office address of Megan Coylewright, MD,MPH,FACC?
The office of Megan Coylewright, MD,MPH,FACC is located at: Erlanger Medical Center, Chattanooga, Tennessee 37403 United States. This is the address for their practice at the Erlanger Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.